Serratagenic acid (Triterpenoid saponin)

Serratagenic acid is a triterpenoid saponin compound found in certain plants used in traditional Ayurvedic medicine. Preliminary computational studies suggest it may exhibit antiviral properties by potentially inhibiting viral RNA polymerase and spike protein interactions.

Origin & History

Serratagenic acid is a triterpenoid saponin found in various medicinal plants, particularly those in the Araliaceae family. It is characterized by a triterpenoid aglycone core with attached sugar moieties, identified through advanced phytochemical profiling techniques such as UPLC-QTOF-MS.

Historical & Cultural Context

Serratagenic acid is found in plants used in Ayurvedic medicine, as indicated by computational studies of Ayurvedic medicinal plants. However, specific traditional applications, duration of historical use, and preparation methods are not documented in available sources.

Health Benefits

• Potential antiviral activity against SARS-CoV-2 through RNA polymerase and spike protein inhibition (preliminary computational evidence only)
• No human clinical evidence available for verified health benefits
• Traditional use context suggests potential benefits from parent plants in Ayurvedic medicine (specific benefits not documented)
• Multiple glycosylated forms identified in medicinal plants (health implications not studied)
• Safety profile suggested through computational ADMET modeling only (no clinical validation)

How It Works

Serratagenic acid appears to work through molecular docking interactions with viral proteins, specifically targeting SARS-CoV-2 RNA-dependent RNA polymerase and spike protein binding sites. Computational modeling suggests this triterpenoid saponin may interfere with viral replication processes and cellular entry mechanisms. However, these mechanisms are based solely on in silico studies and require experimental validation.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses were identified for serratagenic acid. Current evidence is limited to computational molecular docking studies and phytochemical characterization research. The compound requires clinical translation from theoretical modeling to human studies.

Clinical Summary

Currently, no human clinical trials have been conducted specifically on serratagenic acid. The available research consists only of computational modeling studies that suggest potential antiviral activity against SARS-CoV-2. These preliminary in silico findings have not been validated through laboratory or clinical testing. The compound's safety profile, effective dosages, and actual therapeutic benefits in humans remain completely unknown due to the absence of clinical evidence.

Nutritional Profile

Serratagenic acid is a pentacyclic triterpenoid aglycone (saponin backbone) with molecular formula C30H46O5 and molecular weight approximately 490.68 g/mol. As a pure isolated triterpenoid compound, it contains no macronutrients (zero protein, carbohydrate, or fat content in isolated form), no dietary fiber, and no vitamins or minerals. Bioactive profile centers on its oleanane-type triterpenoid skeleton featuring a carboxylic acid group at C-28 and hydroxyl substituents characteristic of saponin aglycones. Found naturally in plants such as Astragalus species and Caragana species at trace concentrations typically ranging from 0.01–0.5% dry weight of plant material, though precise quantification data for serratagenic acid specifically remains limited in published literature. Occurs in glycosylated forms (saponins) in planta, where sugar moieties attached at C-3 affect solubility and bioavailability; the aglycone form (serratagenic acid itself) is released upon hydrolysis of these glycosides. Oral bioavailability of triterpenoid saponin aglycones is generally low (estimated <5–10%) due to poor aqueous solubility and limited intestinal absorption, though gut microbiota hydrolysis of parent glycosides can generate the free aglycone in the gastrointestinal tract. No caloric value is nutritionally relevant at physiological exposure concentrations. Log P value estimated >4, indicating high lipophilicity relevant to membrane interaction and distribution.

Preparation & Dosage

No clinically studied dosage ranges are available for serratagenic acid as an isolated compound or standardized extract. Dosage information cannot be provided without human clinical trial data. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other triterpenoid saponins, Ayurvedic herbs, antiviral botanicals

Safety & Interactions

No safety data exists for serratagenic acid as an isolated compound, as it has not been studied in human trials. Potential side effects, drug interactions, and contraindications are unknown due to lack of clinical research. Pregnant and breastfeeding women should avoid this compound due to insufficient safety information. Individuals taking medications or with underlying health conditions should consult healthcare providers before considering supplements containing this compound.